Title

Evaluation of the Efficacy of Vacquinol-1 In Glioblastoma Multiforme

School Name

South Carolina Governor's School for Science & Mathematics

Grade Level

12th Grade

Presentation Topic

Cell and Molecular Biology

Presentation Type

Mentored

Abstract

Glioblastoma Multiforme is a malignant and aggressive tumor that accounts for over 80% of brain tumors. Only half of the patients diagnosed survive even after chemotherapy and radiotherapy. In efforts to increase these survival rates, new treatments are being analyzed. One of these new treatments include Vacquinol-1, a drug used to kill GBM cells through methuosis. Methuosis is a form of cell death that is non-apoptotic, differing from the apoptotic forms of cell death used by chemotherapy and radiotherapy. Methuosis exclusively kills the cancerous cells, through a process called catastrophic vacuolization, while leaving the healthy cells alive.

Location

Furman Hall 107

Start Date

3-28-2020 11:45 AM

Presentation Format

Oral Only

Group Project

No

COinS
 
Mar 28th, 11:45 AM

Evaluation of the Efficacy of Vacquinol-1 In Glioblastoma Multiforme

Furman Hall 107

Glioblastoma Multiforme is a malignant and aggressive tumor that accounts for over 80% of brain tumors. Only half of the patients diagnosed survive even after chemotherapy and radiotherapy. In efforts to increase these survival rates, new treatments are being analyzed. One of these new treatments include Vacquinol-1, a drug used to kill GBM cells through methuosis. Methuosis is a form of cell death that is non-apoptotic, differing from the apoptotic forms of cell death used by chemotherapy and radiotherapy. Methuosis exclusively kills the cancerous cells, through a process called catastrophic vacuolization, while leaving the healthy cells alive.